KP

Kumarapillai Parameswaran Srinivasakumar

Active Director Director DIN 08561862
DIN 08561862 First appointment Sep 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Sep 2019
Shareholding value •••• Premium profile

About Kumarapillai Parameswaran Srinivasakumar

Data last updated:

Kumarapillai Parameswaran Srinivasakumar is a Director at Spectrax Medcenter For Analytical Research & Training Private Limited (since 2023), Director at Prawnrx Healthcare Private Limited (since 2019) and Director at Universality Science Hub For Aspiring Scholars Foundation (since 2025), and holds 1 more current directorship. The companies operate in Healthcare and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹9.79 Cr; the largest is Spectrax Medcenter For Analytical Research & Training Private Limited at ₹9.55 Cr (FY 2025).

DIN 08561862
Primary Designation Director
Industry Healthcare
First Appointment 13 Sep 2019
Oldest Company Age 7 yrs
Combined revenue ₹9.79 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20232023₹9.55 Cr (FY 2025)Active
Prawnrx Healthcare Private Limited U73200KL2019PTC059586
Director13 Sep 20192019₹23.6 Lakh (FY 2025)Active
Director17 May 20252025Active
Inbiotics Private Limited U33119TN2022PTC149942
Director14 Feb 20222022Active

Directorship timeline

Open interactive timeline →
Inbiotics Private Limited
Prawnrx Healthcare Private Limited
Universality Science Hub For Aspiring Scholars Foundation
Spectrax Medcenter For Analytical Research & Training Private Limited
Premium access

Shareholding and investment profile for Kumarapillai Parameswaran Srinivasakumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumarapillai Parameswaran Srinivasakumar

Kumarapillai Parameswaran Srinivasakumar currently holds 4 directorships: Spectrax Medcenter For Analytical Research & Training Private Limited (Director, since 29 May 2023, revenue ₹9.55 Cr (FY 2025)); Prawnrx Healthcare Private Limited (Director, since 13 Sep 2019, revenue ₹23.6 Lakh (FY 2025)); Universality Science Hub For Aspiring Scholars Foundation (Director, since 17 May 2025); Inbiotics Private Limited (Director, since 14 Feb 2022).

Kumarapillai Parameswaran Srinivasakumar was first appointed on 13 Sep 2019 as Director at Prawnrx Healthcare Private Limited. The most recent appointment on record is 17 May 2025 at Universality Science Hub For Aspiring Scholars Foundation.

The 2 current companies of Kumarapillai Parameswaran Srinivasakumar that report revenue have a combined latest revenue of ₹9.79 Cr: Spectrax Medcenter For Analytical Research & Training Private Limited ₹9.55 Cr (FY 2025); Prawnrx Healthcare Private Limited ₹23.6 Lakh (FY 2025).

The current boards of Kumarapillai Parameswaran Srinivasakumar's companies include Jacob Paulraj Vimal (Spectrax Medcenter For Analytical Research & Training Private Limited), Nigith Premachandran Nair Valsalakumari (Spectrax Medcenter For Analytical Research & Training Private Limited), Rajakumar (Spectrax Medcenter For Analytical Research & Training Private Limited), Samji (Spectrax Medcenter For Analytical Research & Training Private Limited), Thangavel Santosh Kumar (Spectrax Medcenter For Analytical Research & Training Private Limited), Thankayyan Chandra Das (Spectrax Medcenter For Analytical Research & Training Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available